Pfizer in the News:

• A remedial strategy for Canada’s changing healthcare industry – Pfizer Canada President, John Helou, shares his thoughts about health care in Canada, Pfizer’s innovation strategy, and why Canada should remain an important place to invest. Click here to read more.
• La Presse interviews Paul Lévesque and discusses the contributions that Pfizer Canada makes to the pharmaceutical industry. Click here.
• Pfizer Canada is one of Canada’s Top Family-Friendly Employers for 2012. Click here.
• Paul Levesque was the keynote speaker at the Economic Club of Canada in Toronto on Tuesday, November 1, 2011 where he debunked the “Top 10 Myths of the Pharmaceutical Industry.” You can listen to Mr. Levesque’s presentation by clicking here. Please note that the presentation was delivered in English.
• Paul Lévesque, president of Pfizer Canada, talks about the importance of research & development in Canada.
• On Thursday, September 22, 2011, Paul Lévesque was the guest speaker at the Toronto Board of Trade's Pfizer Healthcare Series luncheon event. Paul’s presentation titled “ Innovation: Driving Health and Wealth for the GTA, Ontario and Canada,” was extremely well received by the audience of over 150 guests, including several media in attendance.You can listen to Mr. Lévesque’s presentation by clicking here. Please note that the presentation was done in English.
• On Tuesday, May 17, Paul Lévesque was the guest speaker at the Board of Trade of Metropolitan Montreal’s “Hot Issues@Lunch” networking event.
  Mr. Lévesque’s presentation titled “Reality Check – The Top 10 Myths about the Pharmaceutical Industry” was extremely well received by the audience of over 400 guests and generated significant media interest following the event.
  You can listen to Mr. Lévesque’s presentation by clicking here. Please note that the presentation was done mostly in French.
• Mr. Paul Lévesque, President of Pfizer Canada, writes to The Globe and Mail on the importance of innovation for the economic future of Canada. To view the full article, please click here
• On November 20th 2010, an opinion on Intellectual property: local biotechs want changes here was published in Cyberpresse by Paul Lévesque as Chairman of the Board of Montréal InVivo and President, Pfizer Canada. To view the full opinion, click here. To view the English translated version, click here
• On October 9th 2010, an opinion on Quebec pharma policy was published in Cyberpresse by Paul Lévesque as Chairman of the Board of Montréal InVivo and President, Pfizer Canada. To view the full opinion, click here. To view the English translated version, click here 
• On May 3rd 2010, an opinion on the role of Montreal in the life sciences and health technology sector was published in Cyberpresse by Paul Lévesque as Chairman of the Board of Montréal InVivo and President, Pfizer Canada. To view the full opinion, click here. To view the English translated version, click here 
• An article on Quebec's Pain Research Network was published in the March 2009 issue of the Fonds de la recherche en santé du Québec (FRSQ) magazine, Recherche en santé. Pfizer Canada is mentioned as one of the partners, including AstraZeneca, Quebec's Health and Social Services Ministry (MSSS) and FRSQ, that donated funds for research and education to improve the understanding of chronic pain and help doctors diagnose and treat pain more efficiently. This unique public-private partnership was first announced in February 2008. To view the article, please click here 
• In February 2009, an article about Pfizer Canada's VIVA program was featured in journal Les Affaires. In the article, Pfizer Canada's Vice President of Human Resources, Luc St-Pierre, talks about the recession and its impact on business choices related to human resources and training. To view the full article, please click here 
• With the biopharmaceutical industry well established in the province of Quebec, a strong academic network and demonstrated innovation capabilities, the industry has everything to succeed. But what's missing? This is the topic of a special biopharmaceutical report that was covered in Les Affaires in March 2009. Pfizer Canada's President, Paul Lévesque and Vice President and Medical Director Bernard Prigent were featured alongside interviews from government, academia and industry thought leaders. To view the full article, please click here 
• Pfizer Canada President, Paul Lévesque and Vice President and Medical Director, Bernard Prigent, were featured in a March 2009 Globe & Mail report discussing the importance of health research to the country's economy and to Canadians' overall wellness. The report was part of a 6-page stand-alone supplement included in the national edition of the Globe & Mail. To view the full article, please click here